Literature DB >> 6732052

Uptake of antibiotics by human alveolar macrophages.

W L Hand, R W Corwin, T H Steinberg, G D Grossman.   

Abstract

To provide additional criteria for therapy of pulmonary infections caused by facultative intracellular bacteria, we studied the uptake of 12 antibiotics by alveolar macrophages (AM) obtained from healthy, young volunteers by bronchoalveolar lavage. These human AM were incubated with radiolabeled antibiotics for periods as long as 2 h. Entry of antimicrobials into the cells was determined by means of a velocity-gradient centrifugation technique. Antibiotic uptake was expressed as the ratio of the cellular to the extracellular drug concentration (C/E). Penicillin G, cefamandole, and gentamicin were taken up poorly by human AM (C/E = 0.5 to 0.8). Isoniazid achieved a cellular concentration similar to the extracellular level of the drug (C/E = 0.9). Chloramphenicol, rifampin, tetracycline, and lincomycin, drugs that are lipid-soluble, were concentrated several-fold by AM (C/E = 2 to 5). The remaining antibiotics tested, clindamycin, erythromycin, erythromycin propionate, and ethambutol, were markedly concentrated by AM (C/E = 9 to 23). Accumulation of clindamycin (C/E = 23) was a rapid, active, energy-requiring process, which appeared to be dependent upon mitochondrial oxidative metabolism. The ability of the tested antimicrobial agents to enter human AM correlates well with the efficacy of these drugs in treatment of certain intracellular pulmonary infections.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6732052     DOI: 10.1164/arrd.1984.129.6.933

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  39 in total

1.  In silico children and the glass mouse model: clinical trial simulations to identify and individualize optimal isoniazid doses in children with tuberculosis.

Authors:  Prakash M Jeena; William R Bishai; Jotam G Pasipanodya; Tawanda Gumbo
Journal:  Antimicrob Agents Chemother       Date:  2010-11-22       Impact factor: 5.191

2.  Survival of Enterococcus faecalis in mouse peritoneal macrophages.

Authors:  C R Gentry-Weeks; R Karkhoff-Schweizer; A Pikis; M Estay; J M Keith
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

Review 3.  Comparative pharmacokinetics and pharmacodynamics of the rifamycin antibacterials.

Authors:  W J Burman; K Gallicano; C Peloquin
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

4.  Sequencing of the rpoB gene in Legionella pneumophila and characterization of mutations associated with rifampin resistance in the Legionellaceae.

Authors:  K Nielsen; P Hindersson; N Hoiby; J M Bangsborg
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

5.  Effects of gender, AIDS, and acetylator status on intrapulmonary concentrations of isoniazid.

Authors:  John E Conte; Jeffrey A Golden; Mari McQuitty; Juliana Kipps; Sheila Duncan; Elaine McKenna; Elisabeth Zurlinden
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

6.  Gentamicin kills intracellular Listeria monocytogenes.

Authors:  D A Drevets; B P Canono; P J Leenen; P A Campbell
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

7.  Contrasts between phagocyte antibiotic uptake and subsequent intracellular bactericidal activity.

Authors:  W L Hand; N L King-Thompson
Journal:  Antimicrob Agents Chemother       Date:  1986-01       Impact factor: 5.191

8.  Macrophage-enhanced germination of Bacillus anthracis endospores requires gerS.

Authors:  John A W Ireland; Philip C Hanna
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

9.  Interactions of dirithromycin with human polymorphonuclear leukocytes.

Authors:  W L Hand; D L Hand
Journal:  Antimicrob Agents Chemother       Date:  1993-12       Impact factor: 5.191

10.  Determination of pefloxacin concentration in mesenteric lymph nodes by high-performance chromatography.

Authors:  M I Munera; F Cuesta; A Abadia; J Vasquez; M Restrepo
Journal:  Antimicrob Agents Chemother       Date:  1994-03       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.